Sensitive and selective LC-MS-MS assay for the quantification of palonosetron in human plasma and its application to a pharmacokinetic study

Chromatographia

Volumn 68, Issue 3-4, 2008, Pages 193-199

  Zhang, Wen ^a   Feng, Fang ^a   Le, Wen ^a   Wang, Hang ^a   Zhu, Lan ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Liquid chromatography tandem mass spectrometry; Palonosetron; Pharmacokinetics

Indexed keywords

BICARBONATE; CITALOPRAM; PALONOSETRON;

ACCURACY; ADULT; ALKALINITY; ARTICLE; CALIBRATION; CONTROLLED STUDY; DRUG DETERMINATION; DRUG MONITORING; DRUG STABILITY; DRUG STRUCTURE; ELECTROSPRAY; FEMALE; HUMAN; HUMAN EXPERIMENT; LIQUID CHROMATOGRAPHY; LIQUID LIQUID EXTRACTION; MALE; NORMAL HUMAN; PLASMA; PRIORITY JOURNAL; QUALITY CONTROL; QUANTITATIVE ANALYSIS; SINGLE DRUG DOSE; STANDARD; TANDEM MASS SPECTROMETRY; VOLUNTEER;

EID: 48349135581     PISSN: 00095893     EISSN: 16121112     Source Type: Journal    
DOI: 10.1365/s10337-008-0712-5     Document Type: Article

References (9)

1. GG Abdelsayed 2007 Exp Hematol 35 34 36 10.1016/j.exphem.2007.01.010
2. AD Leon 2006 Proc (Bayl Univ Med Cent) 19 413 416
3. http://www.fda.gov/cder/foi/label/2003/21372_aloxi_lbl.pdf
4. R Stoltz JC Cyong A Shah S Parisi 2004 J Clin Pharmacol 44 520 531 10.1177/0091270004264641
5. TL Hunt SC Gallagher M Cullen AK Shah 2005 J Clin Pharmacol 45 589 596 10.1177/0091270005275061
6. L Ding Y Chen L Yang A Wen 2007 J Pharm Biomed Anal 44 575 580 10.1016/j.jpba.2006.10.019
7. FDA Guidance for Industry (2001) Bioanalytical method validation, Center for Drug Evaluation and Research, U.S. Department of Health and Human Services
8. PJ Taylor 2005 Clin Biochem 38 328 334 10.1016/j.clinbiochem.2004.11.007
9. R Dams MA Huestis WE Lambert CM Murphy 2003 J Am Soc Mass Spectrom 14 1290 1294 10.1016/S1044-0305(03)00574-9